benzyl N-[(1R,2S)-1-[3,5-bis(trifluoromethyl)phenyl]-1-hydroxypropan-2-yl]carbamate

We are benzyl N-[(1R,2S)-1-[3,5-bis(trifluoromethyl)phenyl]-1-hydroxypropan-2-yl]carbamate CAS:877384-16-2 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name: benzyl N-[(1R,2S)-1-[3,5-bis(trifluoromethyl)phenyl]-1-hydroxypropan-2-yl]carbamate
CAS.NO: 877384-16-2
Synonyms:
[(1S,2R)-2-[3,5-Bis(trifluoromethyl)phenyl]-2-hydroxy-1-methylethyl]carbamic acid phenylmethyl ester
benzyl (1R,2S)-1-(3,5-bis(trifluoromethyl)phenyl)-1-hydroxypropan-2-ylcarbamate
(1R,2S)-1-(3',5'-bis(trifluoromethyl)phenyl)-2-benzyloxycarbonylamino-1-propanol

Molecular Formula:C19H17F6NO3
Molecular Weight:421.33400

Physical and Chemical Properties:
Density: 1.4±0.1 g/cm3
Boiling point: 442.8±45.0 °C at 760 mmHg
Melting point: /
Flash point:221.6±28.7 °C
Refractive index: 1.498

Specification:
Appearance: White  powder
Purity:≥99%
Moisture Content: ≤0.5%

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage:Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Anacetrapib CAS:875446-37-0

Related News: Under the terms of this agreement, Inceptua will support Onconova through the pre-approval provision of intravenous rigosertib initially into a number of countries including: Australia, Denmark, Finland, France, Ireland, Italy, the Netherlands, Portugal, South Africa, Spain, and the UK.39512-49-7 Refers to the active pharmaceutical ingredients used in the manufacture of original research drugs (patent drugs or innovative drugs). It mainly meets the needs of international original research drug companies and emerging biopharmaceutical companies for innovative drugs at various stages of clinical research, registration approval and commercialization of drugs. Contains advanced intermediates used in the manufacture of this drug substance that need to be regulated by regulatory authorities.2-Phenylacetamide Refers to the active pharmaceutical ingredients used in the manufacture of original research drugs (patent drugs or innovative drugs). It mainly meets the needs of international original research drug companies and emerging biopharmaceutical companies for innovative drugs at various stages of clinical research, registration approval and commercialization of drugs. Contains advanced intermediates used in the manufacture of this drug substance that need to be regulated by regulatory authorities.3972-65-4 Microarrays of over 5,500 plasma membrane and secreted protein targets are expressed in human cells.In order to seize the highest point of profits, international industry giants have adjusted their development strategies, concentrated their energies on the two ends of the smile curve-research and development and end products, and shifted production links such as intermediates and APIs outward. A division of labor model has been formed.